Search - tctmd.com

Displaying 141 - 160 of 333

Sort: Relevancy | Date

Presentation TCT 2014

Early Stage or Uncontrolled Hypertension!

Presenter: Darrel P. Francis

September 14, 2014

Presentation TCT 2014

TCT 406: Renal Artery Trauma Induced by Four Different Renal Denervation Systems: A Multimodality Intraarterial Imaging Study

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, Antonios Karanasos

September 14, 2014

Presentation TCT 2014

Updates and Status of the Cordis Renlane Program

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, Felix Mahfoud

September 14, 2014

Presentation TCT 2014

Updates and Status of the ReCor Paradise Program

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, Thomas Zeller

September 14, 2014

Presentation TCT 2014

Going to the Source: Early Clinical Results with the Afferently Directed Nonvascular Renal Denervation System (Verve Medical)

Presenter: Frank Litvack, Richard R. Heuser

September 14, 2014

Presentation TCT 2014

Updates and Status of the St. Jude EnligHTN Program

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray

September 14, 2014

Presentation TCT 2014

Endovascular Interventions: Lower Extremity, Aorta, Renal, and Carotid Disease

Presenter: Thomas T. Tsai, Satya Reddy Atmakuri

September 14, 2014

Presentation TCT 2014

Updates and Status of the Boston Scientific Vessix Program

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, Ajay J. Kirtane

September 14, 2014

Presentation TCT 2014

From SYMPLICITY HTN-1 to the Global SYMPLICITY Registry and Beyond: Updates from and Status of the SYMPLICITY Clinical Trial Program

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, Michael Boehm

September 14, 2014

Presentation TCT 2014

TCT 405: SYMPLICITY HTN-3: Outcomes in the African-American and NonAfrican American Populations

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, John Flack

September 14, 2014

Presentation TCT 2014

First Deep Dive into SYMPLICITY HTN-3: Primary Results and Updated Analyses

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray

September 14, 2014

Presentation TCT 2014

Renal Denervation: Boom or Bust?

Presenter: Martina Kelly Speight, Sarah Clarke, Ajay J. Kirtane

September 14, 2014

Presentation TCT 2014

Second Deep Dive into SYMPLICITY HTN-3: Novel Mechanistic Insights from the Trial

Presenter: David Kandzari

September 14, 2014

Presentation TCT 2014

Is Renal Denervation a Blockbuster Therapy or Have We Ground to a Halt?

Presenter: Jose Luis Assad-Morell, Efrain Gaxiola, Armando Tellez

September 13, 2014

Presentation TCT 2014

Guidelines and Recommendations for the Practical Application of Renal Denervation Therapies in a Post-SYMPLICITY 3 World

Presenter: Ajay J. Kirtane, Felix Mahfoud, John A. Ormiston, Thomas F. Luscher

September 13, 2014

Presentation TCT 2014

Current Status of Advanced Hypertension Treatment in the United States

Presenter: Ajay J. Kirtane, Felix Mahfoud, John A. Ormiston, Michael A. Weber

September 13, 2014

Presentation TCT 2014

What it Means to Have (and Be) a Hypertension Referral Center

Presenter: Ajay J. Kirtane, Felix Mahfoud, John A. Ormiston, C. Venkata S. Ram

September 13, 2014

Presentation TCT 2014

Workup and Treatment of Hypertension: From A to Z

Presenter: Ajay J. Kirtane, Felix Mahfoud, John A. Ormiston, Atul Pathak

September 13, 2014

Presentation TCT 2014

Essentials of Mapping the Renal Nerves In Vivo

Presenter: Krishna J. Rocha-Singh, Stephen G. Worthley, Robert S. Schwartz, Jie Wang

September 13, 2014

Presentation TCT 2014

Essentials of Chemical Ablation

Presenter: Krishna J. Rocha-Singh, Stephen G. Worthley, Robert S. Schwartz, Tim A. Fischell

September 13, 2014

Advertisement

Early Stage or Uncontrolled Hypertension!

TCT 406: Renal Artery Trauma Induced by Four Different Renal Denervation Systems: A Multimodality Intraarterial Imaging Study

Updates and Status of the Cordis Renlane Program

Updates and Status of the ReCor Paradise Program

Going to the Source: Early Clinical Results with the Afferently Directed Nonvascular Renal Denervation System (Verve Medical)

Updates and Status of the St. Jude EnligHTN Program

Endovascular Interventions: Lower Extremity, Aorta, Renal, and Carotid Disease

Updates and Status of the Boston Scientific Vessix Program

From SYMPLICITY HTN-1 to the Global SYMPLICITY Registry and Beyond: Updates from and Status of the SYMPLICITY Clinical Trial Program

TCT 405: SYMPLICITY HTN-3: Outcomes in the African-American and NonAfrican American Populations

First Deep Dive into SYMPLICITY HTN-3: Primary Results and Updated Analyses

Renal Denervation: Boom or Bust?

Second Deep Dive into SYMPLICITY HTN-3: Novel Mechanistic Insights from the Trial

Is Renal Denervation a Blockbuster Therapy or Have We Ground to a Halt?

Guidelines and Recommendations for the Practical Application of Renal Denervation Therapies in a Post-SYMPLICITY 3 World

Current Status of Advanced Hypertension Treatment in the United States

What it Means to Have (and Be) a Hypertension Referral Center

Workup and Treatment of Hypertension: From A to Z

Essentials of Mapping the Renal Nerves In Vivo

Essentials of Chemical Ablation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content